MEGHAN YOUNG: Open Payments
NPI 1093350464 · HOMER, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 51 payments from 12 companies in 2025. Trend: 2023 $302 · 2024 $502 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $267 |
| Janssen Biotech, Inc. | 13 | $164 |
| Ardelyx, Inc. | 6 | $94 |
| GENZYME CORPORATION | 4 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
Products named: RINVOQ, TREMFYA, IBSRELA, DUPIXENT, XIFAXAN, EOHILIA, OMVOH, LINZESS.
Industry payments across AK — which companies pay providers there.
